01 CDYMAX (INDIA) PHARMA PRIVATE LIMITED Bangalore IN (2)
02 CIPLA LIMITED Mumbai IN (1)
03 DEVA HOLDING A.Ş. Istanbul TR (1)
04 F.I.S. - Fabbrica Italiana Sintetici S.p.A. Montecchio Maggiore IT (1)
05 HETERO LABS LIMITED Hyderabad IN (3)
06 INTAS PHARMACEUTICALS LIMITED Ahmedabad IN (1)
07 Ind-Swift Laboratories Limited Chandigarh IN (1)
08 LAURUS LABS LIMITED Hyderabad IN (2)
09 MSN LABORATORIES PRIVATE LIMITED Kardanur Village IN (1)
10 NATCO PHARMA LIMITED Hyderabad IN (1)
11 SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town CN (2)
12 SHILPA PHARMA LIFESCIENCES LIMITED Raichur IN (1)
13 SIGNA S.A. DE C.V. Toluca MX (1)
14 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL (1)
15 Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou City CN (1)
01 Imatinib mesilate (9)
02 Imatinib mesilate, Alpha form (1)
03 Imatinib mesilate, Form α (1)
04 Imatinib mesilate, Form α, Process II (1)
05 Imatinib mesilate, Form-α (2)
06 Imatinib mesilate, Form-β (1)
07 Imatinib mesilate, Process 2 (1)
08 Imatinib mesilate, Process II (1)
09 Imatinib mesilate, α Form (1)
10 Imatinib mesilate, β form (1)
11 Imatinib mesilate, β-form (1)
01 China (3)
02 India (13)
03 Israel (1)
04 Italy (1)
05 Mexico (1)
06 Turkey (1)
01 Expired (1)
02 Valid (19)
82
PharmaCompass offers a list of Imatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imatinib Mesylate manufacturer or Imatinib Mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imatinib Mesylate manufacturer or Imatinib Mesylate supplier.
PharmaCompass also assists you with knowing the Imatinib Mesylate API Price utilized in the formulation of products. Imatinib Mesylate API Price is not always fixed or binding as the Imatinib Mesylate Price is obtained through a variety of data sources. The Imatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Imatinib Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib Mesylate, including repackagers and relabelers. The FDA regulates Imatinib Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imatinib Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imatinib Mesylate supplier is an individual or a company that provides Imatinib Mesylate active pharmaceutical ingredient (API) or Imatinib Mesylate finished formulations upon request. The Imatinib Mesylate suppliers may include Imatinib Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Imatinib Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imatinib Mesylate CEP of the European Pharmacopoeia monograph is often referred to as a Imatinib Mesylate Certificate of Suitability (COS). The purpose of a Imatinib Mesylate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Imatinib Mesylate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Imatinib Mesylate to their clients by showing that a Imatinib Mesylate CEP has been issued for it. The manufacturer submits a Imatinib Mesylate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Imatinib Mesylate CEP holder for the record. Additionally, the data presented in the Imatinib Mesylate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Imatinib Mesylate DMF.
A Imatinib Mesylate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Imatinib Mesylate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Imatinib Mesylate suppliers with CEP (COS) on PharmaCompass.
We have 15 companies offering Imatinib Mesylate
Get in contact with the supplier of your choice: